Skip to main content
Article
Phase I study of alpha-tocopherlyoxyacetic acid in patients with advanced cancer.
Journal for ImmunoTherapy of Cancer (2015)
  • Brendan D Curti, Providence Portland Medical Center
  • Emmanuel Akporiaye, Qatar Airways
  • Kim Sutcliffe, Providence Portland Medical Center
  • Keith S Bahjat, Providence Portland Medical Center
  • Yoshinobu Koguchi, Providence Portland Medical Center
  • Julie Cramer, Providence Portland Medical Center
  • Walter Urba
Publication Date
January 1, 2015
DOI
10.1186/2051-1426-3-S2-P148
Citation Information
Brendan D Curti, Emmanuel Akporiaye, Kim Sutcliffe, Keith S Bahjat, et al.. "Phase I study of alpha-tocopherlyoxyacetic acid in patients with advanced cancer." Journal for ImmunoTherapy of Cancer Vol. 3 Iss. 2 (2015) p. 148
Available at: http://works.bepress.com/walter-urba/127/